Prevalence of heparin-induced antibody in African-American hemodialysis patients--comparison to non-dialysis patients.

AIMS Heparin-induced antibody formation and thrombocytopenia are well-established complications of heparin use and may be associated with thromboembolic events. Our study aimed to establish the prevalence of heparin-induced antibodies (HIA), otherwise known as platelet factor 4 (PF4) antibodies, and their relationship to thrombocytopenia and thrombotic… CONTINUE READING